Javascript must be enabled to continue!
Targeted Long-Read Bisulfite Sequencing for Promoter Methylation Analysis in Severe Preterm Birth
View through CrossRef
Abstract
DNA methylation plays a critical role in the dynamics of gene expression regulation and the development of various disorders. Whole-genome bisulfite sequencing can provide single base resolution of CpG methylation levels and is the “gold standard” for DNA methylation quantification, but it also has a high cost. In contrast, targeted sequencing is optimal when focusing on specific candidate regions, while providing sufficient sequencing depth. Here, we present a targeted bisulfite sequencing approach to study the methylation status of regions of interest. We amplify selected regions from bisulfite-treated DNA and sequence them using Nanopore sequencing. In this work, we applied this workflow to candidate gene promoters for severe premature labor in a Latin American population.
We successfully amplified fragments over 1 Kb in length using long PCR conditions for 12 genes that were barcoded per sample and pooled to be sequenced on MinION flow cells. This approach achieved high sequencing depths, ensuring reliable DNAm estimation. We found significant hypomethylation of the
MIR155HG
gene promoter in severe preterm birth samples, which is concordant with reported gene expression changes.
We demonstrate that combining bisulfite DNA treatment with pooled long-read sequencing is a cost- and time-effective method to evaluate DNAm in several targeted regions and several samples in parallel. This study provides proof-of-concept for larger studies, demonstrating the applicability and high scalability of our assay to any locus of interest. Our experience suggests that this approach can be easily transferred to other diagnostic questions.
Title: Targeted Long-Read Bisulfite Sequencing for Promoter Methylation Analysis in Severe Preterm Birth
Description:
Abstract
DNA methylation plays a critical role in the dynamics of gene expression regulation and the development of various disorders.
Whole-genome bisulfite sequencing can provide single base resolution of CpG methylation levels and is the “gold standard” for DNA methylation quantification, but it also has a high cost.
In contrast, targeted sequencing is optimal when focusing on specific candidate regions, while providing sufficient sequencing depth.
Here, we present a targeted bisulfite sequencing approach to study the methylation status of regions of interest.
We amplify selected regions from bisulfite-treated DNA and sequence them using Nanopore sequencing.
In this work, we applied this workflow to candidate gene promoters for severe premature labor in a Latin American population.
We successfully amplified fragments over 1 Kb in length using long PCR conditions for 12 genes that were barcoded per sample and pooled to be sequenced on MinION flow cells.
This approach achieved high sequencing depths, ensuring reliable DNAm estimation.
We found significant hypomethylation of the
MIR155HG
gene promoter in severe preterm birth samples, which is concordant with reported gene expression changes.
We demonstrate that combining bisulfite DNA treatment with pooled long-read sequencing is a cost- and time-effective method to evaluate DNAm in several targeted regions and several samples in parallel.
This study provides proof-of-concept for larger studies, demonstrating the applicability and high scalability of our assay to any locus of interest.
Our experience suggests that this approach can be easily transferred to other diagnostic questions.
Related Results
BiSulfite Bolt: A bisulfite sequencing analysis platform
BiSulfite Bolt: A bisulfite sequencing analysis platform
Abstract
Background
Bisulfite sequencing is commonly used to measure DNA methylation. Processing bisulfite sequencing data is of...
Classification and heterogeneity of preterm birth
Classification and heterogeneity of preterm birth
Three main conditions explain preterm birth: medically indicated (iatrogenic) preterm birth (25%; 18.7–35.2%), preterm premature rupture of membranes (PPROM) (25%; 7.1–51.2%) and s...
BiSulfite Bolt: A BiSulfite Sequencing Analysis Platform
BiSulfite Bolt: A BiSulfite Sequencing Analysis Platform
AbstractBackgroundBisulfite sequencing is commonly employed to measure DNA methylation. Processing bisulfite sequencing data is often challenging due to the computational demands o...
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation
Abstract
Background
DNA methylation is an important type of epigenetic modification involved in gene regulation. Although strong DNA...
Abstract 1425: Prognostic significance of promoter DNA methylation in patients with neuroblastoma
Abstract 1425: Prognostic significance of promoter DNA methylation in patients with neuroblastoma
Abstract
Background: Neuroblastoma is a genetically heterogenic tumor diagnosed in childhood which exhibits broad clinical diversity ranging from rapid disease progr...
O6-Methylguanine-DNA Methyltransferase (MGMT) promoter methylation status of high-grade and low-grade gliomas
O6-Methylguanine-DNA Methyltransferase (MGMT) promoter methylation status of high-grade and low-grade gliomas
Background: O6-methylguanine-DNA methyltransferase (MGMT) is a DNA-repair enzyme that correlates with tumor resistance mechanism to chemotherapy. Methylation of the MGMT promoter i...
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract
BACKGROUND:
5-alpha reductase type 2 (SRD5A2), an enzyme that is critical for prostatic development and growth, is utilized as an inhibitory ...
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
Correcting Methylation Calls in Clinically Relevant Low-Mappability Regions
AbstractDNA methylation is an important component in vital biological functions such as embryonic development, carcinogenesis, and heritable regulation. Accurate methods to assess ...

